Hematopoietic and Lymphoid System Neoplasm Recruiting Phase 1 / 2 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0132171 (Hematopoietic and Lymphoid System Neoplasm)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04022239Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell TransplantTreatment